Omnicell Investor Presentation Deck
4 Strong Balance Sheet
Free cash flow projected
to grow slower than
EBITDA as Omnicell
reinvests in the
transformation to
Advanced Services
Liquidity and capital
structure support
growth strategy
© 2023 Omnicell, Inc.
$32M
$447M
Cash and Cash Equivalents
$210M
$569M
Total Debt
$1,016M
Total Assets
$313M
$2,222M
As of December 31, 2017
$947M
Liquidity¹
$554M
As of September 30, 2023
2. Net Debt / EBITDA = (Total Debt - Cash and Cash Equivalents) / Trailing Twelve Month Non-GAAP EBITDA
DISCLAIMER: See Appendix for a reconciliation of 2017 and Q3-2023 Net Debt / EBITDA and 2017 and Q3-2023 Liquidity to their most directly comparable GAAP financial measures.
$1,187M
Total Equity
1.9x
0.9x
Net Debt / EBITDA²
1. Liquidity Revolver Availability ($500M) + Cash and Cash Equivalents ($447M); As of October 10, 2023, the Company entered into a Second Amended and Restated Credit Agreement under which $350M of funds
are available. The amount of Revolver Availability is dependent on financial covenants.
12View entire presentation